• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number TRL-230
Medical Device Problem Codes Material Rupture (1546); Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes Capsular Contracture (1761); Seroma (2069)
Date of Event 08/06/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture, baker grade iii.This is a known potential adverse event addressed in the product labeling.
 
Event or Problem Description
Healthcare professional reported right side capsular contracture, baker grade iii.Device remains implanted.
 
Event or Problem Description
Healthcare professional additionally reported right side "bloody seroma" and a "double bubble deformity".Healthcare professional also reported ¿nipple has serous drainage due to bilateral piercings¿; this event is not device related.
 
Additional Manufacturer Narrative
The event of seroma-late is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.
 
Additional Manufacturer Narrative
Device evaluation: visual analysis of the returned device identified: underweight, opening, brown particles.A microscopic analysis was performed which identify sharp edge opening assessed an unidentified tear opening.A dimension measurement in the shell was performed which identify the thickness within specification.Based on the device analysis the final assessment is: a sharp opening due to an unidentified (tear) opening.
 
Event or Problem Description
Patient representative reported "persistent and increasing pain" and "implant in question had ruptured." device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key9318916
Report Number9617229-2019-17687
Device Sequence Number13934981
Product Code FTR
UDI-Device Identifier10888628007697
UDI-Public10888628007697
Combination Product (Y/N)N
Initial Reporter StateMA
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative,consum
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/26/2020
Device Model NumberTRL-230
Device Catalogue NumberTRL-230
Device Lot Number2763449
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/17/2019
Initial Date Received by Manufacturer 10/16/2019
Supplement Date Received by Manufacturer12/10/2019
03/16/2020
Initial Report FDA Received Date11/13/2019
Supplement Report FDA Received Date01/08/2020
04/15/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age23 YR
-
-